Plain-English translation of NCT07642414 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Enso for Migraine program, a comprehensive digital care system designed to help people manage migraines. The program combines an FDA-cleared wearable device that uses neuromodulation technology to relieve acute migraine pain, along with guided exercise videos, breathing exercises, a migraine tracking journal, and access to a care team (physical therapist and health coach) through a smartphone app.
Migraines significantly impact daily life, work, and well-being for millions of people. This trial aims to see whether combining multiple evidence-based approaches—technology, exercise, stress management, and personalized coaching—can reduce how many migraine days people experience each month.
You likely qualify if…
You likely don't qualify if…
First, you would track your migraines daily using an electronic diary for 4 weeks to establish a baseline. If you record at least 4 migraine days and complete the diary at least 80% of the time, you move into the 12-week treatment phase. During those 12 weeks, you would have full access to the digital program (the wearable device, exercise videos, breathing exercises, and your care team) while continuing to track your migraines daily. You would keep taking your regular migraine medications as prescribed and report how the program is working for you.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
United States